The ROE as of December 2025 (TTM) for MedTech Acquisition Corporation (MTAC) is 263.30%

According to MedTech Acquisition Corporation’s latest financial reports and current stock price. The company's current ROE is 263.30%. This represents a change of 295.44% compared to the average of 66.58% of the last 4 quarters.

MedTech Acquisition Corporation (MTAC) Historical ROE (quarterly & annually)

How has MTAC ROE performed in the past?

The mean historical ROE of MedTech Acquisition Corporation over the last ten years is 55.09%. The current 263.30% ROE has changed 377.95% with respect to the historical average. Over the past ten years (40 quarters), MTAC's ROE was at its highest in in the September 2025 quarter at 154.44%. The ROE was at its lowest in in the September 2023 quarter at -15.15%.

MedTech Acquisition Corporation (MTAC) ROE by Quarter and Year

Discovering the peaks and valleys of MedTech Acquisition Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MedTech Acquisition Corporation (MTAC) Average ROE

How has MTAC ROE performed in the past?

The current ROE of MedTech Acquisition Corporation (MTAC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MedTech Acquisition Corporation (MTAC) ROE vs. Peers

How is MTAC’s ROE compared to its peers?

MedTech Acquisition Corporation’s ROE is greater than Noble Rock Acquisition Corporation (-0.02%), less than Aequi Acquisition Corp. (5.63%), greater than Williams Rowland Acquisition Corp. (0.80%), less than Bleuacacia Ltd (2.81%), less than Spectral AI, Inc. (256.07%), greater than Portage Fintech Acquisition Corporation (0.87%), less than Edify Acquisition Corp. (8.50%), greater than Quadro Acquisition One Corp. (0.65%), less than Belong Acquisition Corp. (3.38%), greater than DigiAsia Corp. (-0.18%),

Build a custom stock screener for MedTech Acquisition Corporation (MTAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedTech Acquisition Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MedTech Acquisition Corporation (MTAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MedTech Acquisition Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.